Copenhagen, Denmark – November 13, 2017: IO Biotech announced that two posters summarizing recent preclinical findings in the company’s leading products, IO102 and IO103, were exhibited over the weekend at the Society for Immunotherapy of Cancer (SITC) Annual Meeting, held in National Harbor, Maryland.
